These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7679987)

  • 1. Impaired stimulus-evoked mucus secretion in cystic fibrosis bronchi.
    Rogers DF; Alton EW; Dewar A; Lethem MI; Barnes PJ
    Exp Lung Res; 1993; 19(1):37-53. PubMed ID: 7679987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucous solids and liquid secretion by airways: studies with normal pig, cystic fibrosis human, and non-cystic fibrosis human bronchi.
    Martens CJ; Inglis SK; Valentine VG; Garrison J; Conner GE; Ballard ST
    Am J Physiol Lung Cell Mol Physiol; 2011 Aug; 301(2):L236-46. PubMed ID: 21622844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tachykinins on mucus secretion in human bronchi in vitro.
    Rogers DF; Aursudkij B; Barnes PJ
    Eur J Pharmacol; 1989 Dec; 174(2-3):283-6. PubMed ID: 2483550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro bioelectric properties of bronchial epithelium from transplanted lungs in recipients with cystic fibrosis.
    Tsang VT; Alton EW; Hodson ME; Yacoub M
    Thorax; 1993 Oct; 48(10):1006-11. PubMed ID: 8256229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of anion transport inhibition on mucus secretion by airway submucosal glands.
    Inglis SK; Corboz MR; Taylor AE; Ballard ST
    Am J Physiol; 1997 Feb; 272(2 Pt 1):L372-7. PubMed ID: 9124389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.
    Henke MO; Renner A; Huber RM; Seeds MC; Rubin BK
    Am J Respir Cell Mol Biol; 2004 Jul; 31(1):86-91. PubMed ID: 14988081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β1, β2, and β3 adrenoceptors and Na+/H+ exchanger regulatory factor 1 expression in human bronchi and their modifications in cystic fibrosis.
    Bossard F; Silantieff E; Lavazais-Blancou E; Robay A; Sagan C; Rozec B; Gauthier C
    Am J Respir Cell Mol Biol; 2011 Jan; 44(1):91-8. PubMed ID: 20203292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of airway liquid secretion and its effect on the physical properties of airway mucus.
    Trout L; King M; Feng W; Inglis SK; Ballard ST
    Am J Physiol; 1998 Feb; 274(2):L258-63. PubMed ID: 9486211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucus glycoproteins secreted by respiratory epithelial tissue from cystic fibrosis patients.
    Frates RC; Kaizu TT; Last JA
    Pediatr Res; 1983 Jan; 17(1):30-4. PubMed ID: 6835712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-adrenergic, non-cholinergic neural control of mucus secretion in the airways.
    Ramnarine SI; Rogers DF
    Pulm Pharmacol; 1994 Feb; 7(1):19-33. PubMed ID: 7911691
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioelectric properties of cystic fibrosis airways obtained at heart-lung transplantation.
    Alton EW; Rogers DF; Logan-Sinclair R; Yacoub M; Barnes PJ; Geddes DM
    Thorax; 1992 Dec; 47(12):1010-4. PubMed ID: 1494762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid inhibition of neurally mediated mucus secretion in human bronchi.
    Rogers DF; Barnes PJ
    Lancet; 1989 Apr; 1(8644):930-2. PubMed ID: 2565421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced effect of inhaled beta 2-adrenergic agonists on lung mucociliary clearance in patients with cystic fibrosis.
    Mortensen J; Hansen A; Falk M; Nielsen IK; Groth S
    Chest; 1993 Mar; 103(3):805-11. PubMed ID: 8095449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study.
    Robinson M; Daviskas E; Eberl S; Baker J; Chan HK; Anderson SD; Bye PT
    Eur Respir J; 1999 Sep; 14(3):678-85. PubMed ID: 10543292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCO3- transport in relation to mucus secretion from submucosal glands.
    Joo NS; Krouse ME; Wu JV; Saenz Y; Jayaraman S; Verkman AS; Wine JJ
    JOP; 2001 Jul; 2(4 Suppl):280-4. PubMed ID: 11875272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypic analysis of respiratory mucous sulfation defects in cystic fibrosis.
    Zhang Y; Doranz B; Yankaskas JR; Engelhardt JF
    J Clin Invest; 1995 Dec; 96(6):2997-3004. PubMed ID: 8675672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of cholinergic neurotransmission in guinea-pig airways by opioids.
    Belvisi MG; Stretton CD; Barnes PJ
    Br J Pharmacol; 1990 May; 100(1):131-7. PubMed ID: 1695531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Sensory-efferent' neural control of mucus secretion: characterization using tachykinin receptor antagonists in ferret trachea in vitro.
    Ramnarine SI; Hirayama Y; Barnes PJ; Rogers DF
    Br J Pharmacol; 1994 Dec; 113(4):1183-90. PubMed ID: 7889271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reevaluation of the action of reducing agents on soluble mucus glycoproteins from human bronchial secretion.
    Le Treut A; Lamblin G; Houdret N; Degand P; Roussel P
    Biochimie; 1981; 63(5):425-34. PubMed ID: 7236742
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of non-peptide tachykinin NK(1) receptor antagonists on non-adrenergic, non-cholinergic neurogenic mucus secretion in ferret trachea.
    Khawaja AM; Liu Y; Rogers DF
    Eur J Pharmacol; 1999 Nov; 384(2-3):173-81. PubMed ID: 10611439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.